Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.77 |
| ▸ | RAB9A | P51151 | 4/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.77 |
| ▸ | MEN1 | O00255 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.77 |
| ▸ | USP2 | O75604 | 1/20 | 0.77 |
| ▸ | GAA | P10253 | 1/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.77 |
| ▸ | RARB | P10826 | 6/20 | 0.70 |
| ▸ | RARA | P10276 | 1/20 | 0.57 |
| ▸ | MTOR | P42345 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | STAT3 | P40763 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9636301 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL9636394 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL9636179 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL6665924 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL9227943 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL9221975 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL8596123 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL9229470 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL9636397 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL25953961 | 1.00 | MAPT (0.77) | MAPTRAB9AALDH1A1SMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9933679-B2 | Birefringence improving agent, ferroelectric liquid crystal composition and liquid crystal display device using the agent, and compound | LC VISION, LLC (US) | 2018-04-03 | — | — | US | disclosed |
| US-20160161817-A1 | BIREFRINGENCE IMPROVING AGENT, FERROELECTRIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE AGENT, AND COMPOUND | LC VISION, LLC | 2016-06-09 | — | — | US | disclosed |
| EP-0293763-B1 | SMECTIC LIQUID CRYSTAL MIXTURE | CHISSO CORPORATION (JP) | 1992-07-29 | — | — | EP | disclosed |
| US-4882083-A | CONTAINING OPTICALLY ACTIVE COMPOUND; HIGH SPEED RESPONSE DISPLAY ELEMENT | CHISSO CORPORATION (JP) | 1989-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160161817-A1 | BIREFRINGENCE IMPROVING AGENT, FERROELECTRIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE AGENT, AND COMPOUND | PYCARD, BIRC7, BIRC8 | MAPT 1120/4885RAB9A 1249/4885ALDH1A1 2971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.